Literature DB >> 11170986

Proinflammatory interactions of pneumolysin with human neutrophils.

R Cockeran1, A J Theron, H C Steel, N M Matlola, T J Mitchell, C Feldman, R Anderson.   

Abstract

The effects of pneumolysin on the proinflammatory activity of human neutrophils, as well as on cation fluxes in these cells, have been investigated. Superoxide production, release of elastase, CR3 expression, phospholipase A2 activity, and alterations in membrane potential were measured by use of lucigenin-enhanced chemiluminescence and colorimetric, flow cytometric, radiometric, and spectrofluorimetric procedures, respectively; and cation fluxes were measured by use of 45Ca2+ and 86Rb+ and by fura-2 spectrofluorometry. Pneumolysin at concentrations >1.67 ng/mL caused influx of Ca2+ and increased phospholipase A2 activity and CR3 expression, which were associated with enhanced superoxide production and release of elastase after activation of the cells with the chemotactic tripeptide FMLP. At the same concentrations, pneumolysin caused efflux of K+ and membrane depolarization. The effects of pneumolysin on cation fluxes were not attributable to inhibition of Ca2+-adenosine triphosphatase (ATPase) or Na+, K+-ATPase. Pneumolysin potentiates the proinflammatory activities of neutrophils by a pore-forming mechanism resulting in Ca2+ influx.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170986     DOI: 10.1086/318536

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils.

Authors:  R Cockeran; H C Steel; T J Mitchell; C Feldman; R Anderson
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.

Authors:  Hisashi Baba; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Satoshi Ichiyama; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 3.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

4.  Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.

Authors:  Annette Spreer; Holger Kerstan; Tobias Böttcher; Joachim Gerber; Alexander Siemer; Gregor Zysk; Timothy J Mitchell; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection.

Authors:  Rendong Fang; Kohsuke Tsuchiya; Ikuo Kawamura; Yanna Shen; Hideki Hara; Shunsuke Sakai; Takeshi Yamamoto; Teresa Fernandes-Alnemri; Ruili Yang; Eduardo Hernandez-Cuellar; Sita R Dewamitta; Yanting Xu; Huixin Qu; Emad S Alnemri; Masao Mitsuyama
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 6.  Membrane assembly of the cholesterol-dependent cytolysin pore complex.

Authors:  Eileen M Hotze; Rodney K Tweten
Journal:  Biochim Biophys Acta       Date:  2011-07-31

Review 7.  Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control.

Authors:  G Tintinger; H C Steel; R Anderson
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

8.  Epithelial cells are sensitive detectors of bacterial pore-forming toxins.

Authors:  Adam J Ratner; Karen R Hippe; Jorge L Aguilar; Matthew H Bender; Aaron L Nelson; Jeffrey N Weiser
Journal:  J Biol Chem       Date:  2006-03-06       Impact factor: 5.157

9.  Pneumolysin causes neuronal cell death through mitochondrial damage.

Authors:  Johann S Braun; Olaf Hoffmann; Miriam Schickhaus; Dorette Freyer; Emilie Dagand; Daniela Bermpohl; Tim J Mitchell; Ingo Bechmann; Joerg R Weber
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

10.  MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway.

Authors:  Un-Hwan Ha; Jae Hyang Lim; Hyun-Joong Kim; Weihui Wu; Shouguang Jin; Haidong Xu; Jian-Dong Li
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.